Evidence map›Paper›PMID 36127520›Full record

ArticleCardiovascular and interventional radiology2023

Reply to: Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant Hypertrophy-The Road Towards Level One Evidence.

Remon Korenblik, Christiaan van der Leij, Ronald M van Dam

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Cardiovascular and interventional radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07717437 (DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07717437 recruitingnot on this map

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Typeobservational_patient_registrySponsorMaastricht University Medical CenterRan2021 to 2032Enrolled350ConditionsLiver Cancer, Liver Metastases
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Remon KorenblikDepartment of Surgery, Maastricht University Medical Center, Level 4, PO Box 5800, 6202 AZ, Maastricht, The Netherlands. remon.korenblik@mumc.nl.ORCID 0000-0002-6356-3076
Christiaan van der LeijDepartment of Radiology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Ronald M van DamDepartment of Surgery, Maastricht University Medical Center, Level 4, PO Box 5800, 6202 AZ, Maastricht, The Netherlands. r.vandam@mumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Embolization, TherapeuticLiver NeoplasmsHepatectomyHepatic VeinsHumansHypertrophyLiverLiver RegenerationPortal Vein

Identifiers

PMID36127520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.